Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    20185168 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed
Has Results
Birinapant for Advanced Ovarian, Fallopian Tube, and Peritoneal Cancer
Conditions: Epithelial Ovarian Cancer;   Peritoneal Neoplasms;   Fallopian Tube Neoplasms
Intervention: Drug: Birinapant (TL32711)

Indicates status has not been verified in more than two years